Humana (HUM) stock dropped 7% despite beating Q1 earnings estimates as unchanged full-year guidance and lower Medicare Star Ratings disappointed investors.
Browsing: News
Mercedes-Benz (MBGn) Q1 profit drops 17% to €1.43B amid 27% China sales decline. U.S. market gains 20% while company maintains full-year outlook.
Adidas (ADS) stock surges 9% after Q1 operating profit hits €705M and sales grow 14% currency-neutral, beating analyst expectations significantly.
Amphenol (APH) shares surge 9% after reporting $7.62B Q1 revenue and issuing Q2 guidance well above analyst expectations. Record orders drive optimism.
BigBear.ai (BBAI) stock rose 10%+ on strong volume before Q1 earnings May 5. Analysts forecast up to 45% upside with targets ranging from $5 to $6.
GE HealthCare (GEHC) stock dropped ~10% after Q1 earnings miss and lowered full-year guidance. Revenue beat expectations despite margin pressures.
AbbVie (ABBV) surged 2.5% premarket after beating Q1 estimates with $2.65 EPS and $15B revenue. Company raises 2026 guidance on strong growth momentum.
SoFi Technologies (SOFI) shares dropped 8% despite beating Q1 revenue estimates as Q2 guidance and full-year outlook disappointed Wall Street analysts.
Tesla (TSLA) stock nudged higher after Elon Musk teased Optimus V3 as ‘special,’ but investors remain cautious amid heavy spending and mixed Q1 results.
Nvidia (NVDA) fell 3% on OpenAI revenue concerns, but is the AI chip sell-off overblown? Analysts say demand remains strong across the sector.
Ford (F) reports Q1 earnings Wednesday. Analysts project $1.3B operating profit on $42.7B sales amid aluminum supply constraints and tariff challenges.
SanDisk (SNDK) stock surged 7.8% after Seagate’s strong earnings calmed AI storage demand fears. SanDisk reports Q3 results April 30.
Avis Budget (CAR) shares dropped 17% after reporting Q1 loss of $8.01 per share, missing estimates and extending a 70% decline from its April highs.
Bloom Energy (BE) surges 17% premarket after crushing Q1 with 130% revenue growth, raising guidance, and securing a $335 RBC price target.
AstraZeneca (AZN) stock fell despite Q1 earnings beat with $15.29B revenue and $2.58 EPS. Analysts attribute the drop to momentum already priced in.